Related references
Note: Only part of the references are listed.Sugar sensing by ChREBP/Mondo-Mlx - new insight into downstream regulatory networks and integration of nutrient-derived signals
Essi Havula et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Karin Hoppe-Seyler et al.
TRENDS IN MICROBIOLOGY (2018)
Explanations for the high potency of HPV prophylactic vaccines
John Schiller et al.
VACCINE (2018)
Targeting protein kinase-b3 (akt3) signaling in melanoma
SubbaRao V. Madhunapantula et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Induction of dormancy in hypoxic human papillomavirus-positive cancer cells
Karin Hoppe-Seyler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells
Karin Hoppe-Seyler et al.
VIRUSES-BASEL (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
E. Jonasch et al.
ANNALS OF ONCOLOGY (2017)
Hypoxic reprograming of H3K27me3 and H3K4me3 at the INK4A locus
Soojeong Chang et al.
FEBS LETTERS (2016)
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner
Jianping Guo et al.
SCIENCE (2016)
Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3
Peggy Prickaerts et al.
EPIGENETICS & CHROMATIN (2016)
Quantitative analysis of ChIP-seq data uncovers dynamic and sustained H3K4me3 and H3K27me3 modulation in cancer cells under hypoxia
Michiel E. Adriaens et al.
EPIGENETICS & CHROMATIN (2016)
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
Laia Bruni et al.
LANCET GLOBAL HEALTH (2016)
REST is a hypoxia-responsive transcriptional repressor
Miguel A. S. Cavadas et al.
SCIENTIFIC REPORTS (2016)
Phase II study of PX-866 in recurrent glioblastoma
Marshall W. Pitz et al.
NEURO-ONCOLOGY (2015)
Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells
Anja Honegger et al.
PLOS PATHOGENS (2015)
The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
Antje Dittmann et al.
ACS CHEMICAL BIOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience
Ming-Mo Hou et al.
ONCOTARGET (2014)
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
Filip Janku et al.
CELL REPORTS (2014)
Oncogenic Human Papillomaviruses Activate the Tumor-Associated Lens Epithelial-Derived Growth Factor (LEDGF) Gene
Jenny Leitz et al.
PLOS PATHOGENS (2014)
RhoB Differentially Controls Akt Function in Tumor Cells and Stromal Endothelial Cells during Breast Tumorigenesis
Shiva Kazerounian et al.
CANCER RESEARCH (2013)
Tissue biomarkers as prognostic variables of cervical cancer
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
Hanneke Stegeman et al.
BMC CANCER (2012)
Molecular mechanisms and potential functions of histone demethylases
Susanne Marije Kooistra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Wnt5a Is Strongly Expressed at the Leading Edge in Non-Melanoma Skin Cancer, Forming Active Gradients, while Canonical Wnt Signalling Is Repressed
Celine Pourreyron et al.
PLOS ONE (2012)
Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation
Thomas G. Magaldi et al.
VIROLOGY (2012)
Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Il-Seok Park et al.
CANCER PREVENTION RESEARCH (2011)
Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia
Tin Fan Chai et al.
FEBS LETTERS (2011)
Human Papillomaviruses As Therapeutic Targets in Human Cancer
Karin Hellner et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes
Thomas Guenther et al.
PLOS PATHOGENS (2010)
PI3K inhibitors for cancer treatment: where do we stand?
Sauveur-Michel Maira et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
The Akt kinases Isoform specificity in metabolism and cancer
Eva Gonzalez et al.
CELL CYCLE (2009)
Adrenomedullin Improves Cardiac Expression of Heat-Shock Protein 72 and Tolerance against Ischemia/Reperfusion Injury in Insulin-Resistant Rats
Yasuko Torigoe et al.
ENDOCRINOLOGY (2009)
Oncogenic activities of human papillomaviruses
Margaret E. McLaughlin-Drubin et al.
VIRUS RESEARCH (2009)
Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition
Veronique Calleja et al.
PLOS BIOLOGY (2009)
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
Adrian J. Folkes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Andrew Y. Choo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exploring the specificity of the PI3K family inhibitor LY294002
Severine I. Gharbi et al.
BIOCHEMICAL JOURNAL (2007)
Physiological roles of PKB/Akt isoforms in development and disease
B. Dummler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo
Veronique Calleja et al.
PLOS BIOLOGY (2007)
Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein α by phosphatidylinositol 3-kinase signaling cascade
Jharna Datta et al.
CANCER RESEARCH (2007)
c-Jun promotes cellular survival by suppression of PTEN
K. Hettinger et al.
CELL DEATH AND DIFFERENTIATION (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Function and biological roles of the Dickkopf family of Wnt modulators
C. Niehrs
ONCOGENE (2006)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors
CW Lindsley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120
XH He et al.
CELL RESEARCH (2004)
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development
I Adini et al.
GENES & DEVELOPMENT (2003)
Tandem mass tags:: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS
A Thompson et al.
ANALYTICAL CHEMISTRY (2003)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter
S Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
H Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα
RL Tuttle et al.
NATURE MEDICINE (2001)
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
H Cho et al.
SCIENCE (2001)
Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells
D Beitner-Johnson et al.
CELLULAR SIGNALLING (2001)
Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21CIP-dependent pathways
SI Wells et al.
EMBO JOURNAL (2000)
Rapid induction of senescence in human cervical carcinoma cells
EC Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
